Comparison of Perioperative Standard Fluid Management and Goal-Directed Fluid Management
1 other identifier
interventional
60
1 country
1
Brief Summary
To compare the goal-directed fluid therapy based on the data obtained from the hemodynamic monitoring system, which provides continuous CO, SV and SVV measurements through arterial pressure wave with standard fluid therapy in perioperative fluid management of patients undergoing head and neck surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2019
CompletedFirst Submitted
Initial submission to the registry
January 20, 2021
CompletedFirst Posted
Study publicly available on registry
January 28, 2021
CompletedJanuary 28, 2021
January 1, 2021
1.3 years
January 20, 2021
January 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraoperative fluid balance
the total and additional amount of crystalloid and colloid fluid fluid given during the surgery
during surgery
Secondary Outcomes (9)
Prolonged IMV demand
during 8 hours after surgery
Prolonged oxygen demand
during 8 hours after surgery
Heart rate
during surgery
Blood Pressure
during surgery
hospitalisation time
postoperative period (up to 6 weeks)
- +4 more secondary outcomes
Study Arms (2)
study group
ACTIVE COMPARATORIn the control group, fluid management was set as MAP (Mean arterial pressure) 65 mmHg and above and diuresis 0.5ml/kg/hour and above. Crystalloid infusion at 7ml/kg/hour was started. When SVV value increased to 13% and over in the study group, 250 ml of crystalloid was given in the first stage, and if it continued to be 13% and over, 250 ml of colloid bolus was given. Vasoconstrictor agent was used when SVV was below 13% and MAP was below 65 mmHg.
control group
PLACEBO COMPARATORIn the control group, fluid management was set as MAP (Mean arterial pressure) 65 mmHg and above and diuresis 0.5ml/kg/hour and above. Crystalloid infusion at 7ml/kg/hour was started. They were given 250 ml of crystalloid in the first stage if the MAP was below 65 mmHg, and 250 ml of colloid bolus if the hypotensive episode continued. If hypotension persisted despite these fluid boluses, a vasoconstrictor agent was used. In addition, when the diuresis of the patients was detected at 0.5mg/kg/hr or less, 250 ml of colloid bolus was administered.
Interventions
Crystalloid solution is a true solution and is able to pass through a semipermeable membrane.
Colloid solution is a heterogeneous mixture whose particle size is intermediate between those of a solution and a suspension.
Eligibility Criteria
You may qualify if:
- Volunteering to participate in the study
- ASA classification 1, 2 or 3
- The patients who will undergo head and neck surgery
You may not qualify if:
- Being under the age of 18 or over the age of 80
- Presence of serious cardiac, renal and liver pathology ( ejection fraction\< %35 and/or glomerular filtration rate\< 30ml/kg/min, kreatinin\>2,5mg/dl and/or abnormal liver function test)
- The patients who have heart rhythm problems such as atrial fibrillation, sinus tachycardia, ventricular extrasystoles
- The patients who have a peripheral arterial disease
- Being a morbid obese ( BMI\>40 kg/m2)
- the patients who may have considered difficult airway
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University, Department of Anesthesiology
Istanbul, Fatih, 34093, Turkey (Türkiye)
Related Publications (2)
Davies SJ, Minhas S, Wilson RJ, Yates D, Howell SJ. Comparison of stroke volume and fluid responsiveness measurements in commonly used technologies for goal-directed therapy. J Clin Anesth. 2013 Sep;25(6):466-74. doi: 10.1016/j.jclinane.2013.04.010. Epub 2013 Aug 17.
PMID: 23965199BACKGROUNDFunk D, Bohn J, Mutch W, Hayakawa T, Buchel EW. Goal-directed fluid therapy for microvascular free flap reconstruction following mastectomy: A pilot study. Plast Surg (Oakv). 2015 Winter;23(4):231-4. doi: 10.4172/plastic-surgery.1000937.
PMID: 26665136BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Demet Altun Bingol, Assoc. Prof.
Istanbul University
- PRINCIPAL INVESTIGATOR
Nuray Turkut, MD
Istanbul University
- PRINCIPAL INVESTIGATOR
Cansu Uzuntürk, Resident
Istanbul University
- PRINCIPAL INVESTIGATOR
Emre Çamcı, Prof.
Istanbul University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- attending anesthesiologist
Study Record Dates
First Submitted
January 20, 2021
First Posted
January 28, 2021
Study Start
October 1, 2017
Primary Completion
January 1, 2019
Study Completion
May 1, 2019
Last Updated
January 28, 2021
Record last verified: 2021-01